ADRENALYNN AS: årsregnskap 2024 vs 2023
Shrank 89% on revenue, returned to profit
approved 2025-05-23; registry 2025-05-26; journal 2025 471540
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for ADRENALYNN AS. Revenue 919.0k NOK → 104.2k NOK (-88.7%). Net result -59.8k NOK → +81.1k NOK. Equity -19.5k NOK → 61.6k NOK.
On the constructive side: operating result improved; turned profitable; equity strengthened. Pressures included: revenue fell.
Also worth watching: cogs fell. All figures are taken from the published annual accounts for ADRENALYNN AS.
At a glance
Scorecard
What improved
-
↑
Operating result improved
Operating result -59.0k NOK → +80.7k NOK (op. margin -6.4% → 77.5%). Calculated
-
↑
Turned profitable
Net result flipped from a loss of 59.8k NOK to a profit of 81.1k NOK. Calculated
-
↑
Equity strengthened
Book equity -19.5k NOK → 61.6k NOK (equity ratio -22.4% → 28.9%). Calculated
-
↑
Current ratio back above 1×
Current ratio 0.82× → 1.41×. Calculated
-
↑
Payroll decreased
Salary cost 529.1k NOK → 488.8k NOK (58% → 469% of revenue). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 919.0k NOK to 104.2k NOK (-88.7% YoY). Calculated
Things to notice
-
·
COGS fell
COGS / varekostnad 191.8k NOK → 168.9k NOK (-12.0% YoY). Calculated